RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Biohaven Pharmaceutical Holding Company Stock

Biohaven Pharmaceutical Holding Company ROCE 2024

Biohaven Pharmaceutical Holding Company ROCE

-1.02

Ticker

BHVN

ISIN

VGG111961055

WKN

A2DQ7W

In 2024, Biohaven Pharmaceutical Holding Company's return on capital employed (ROCE) was -1.02, a -3.34% increase from the -1.05 ROCE in the previous year.

Biohaven Pharmaceutical Holding Company Aktienanalyse

What does Biohaven Pharmaceutical Holding Company do?

Biohaven Pharmaceutical is a biopharmaceutical company focused on developing innovative therapies for neurological disorders. It was founded in 2013 and is headquartered in New Haven, Connecticut. The company's business model is based on discovering and developing novel medications for conditions such as migraine, spinal muscular atrophy, Alzheimer's, and other neurological disorders. Biohaven invests in research and development to create therapies that can enhance patients' lives. It has divisions dedicated to developing treatments for migraine, neurodegeneration, and spinal muscular atrophy. Biohaven's first product, Rimegepant, is a migraine medication that inhibits the CGRP receptor. It has been approved in the US for migraine treatment. Troriluzol, another migraine medication, is still in clinical development. Biohaven is also active in the fields of Alzheimer's and ALS, with medications like BHV-0223 and BHV-4157 in development. The company aims to develop innovative medications that can improve and restore patient health. It collaborates with other companies and research institutions to maximize its research potential and bring innovative therapies to market faster. Overall, Biohaven Pharmaceutical is a leading biopharmaceutical company dedicated to developing innovative therapies for neurological disorders, with a strong pipeline of medications and a committed research and development department working towards improving global patient healthcare. Biohaven Pharmaceutical Holding Company ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Biohaven Pharmaceutical Holding Company's Return on Capital Employed (ROCE)

Biohaven Pharmaceutical Holding Company's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Biohaven Pharmaceutical Holding Company's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Biohaven Pharmaceutical Holding Company's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Biohaven Pharmaceutical Holding Company’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Biohaven Pharmaceutical Holding Company stock

What is the ROCE (Return on Capital Employed) of Biohaven Pharmaceutical Holding Company this year?

The ROCE of Biohaven Pharmaceutical Holding Company is -1.02 undefined this year.

How has the ROCE (Return on Capital Employed) of Biohaven Pharmaceutical Holding Company developed compared to the previous year?

The ROCE of Biohaven Pharmaceutical Holding Company has increased by -3.34% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Biohaven Pharmaceutical Holding Company?

A high Return on Capital Employed (ROCE) indicates that Biohaven Pharmaceutical Holding Company has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Biohaven Pharmaceutical Holding Company?

A low ROCE (Return on Capital Employed) can indicate that Biohaven Pharmaceutical Holding Company has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Biohaven Pharmaceutical Holding Company impact the company?

An increase in the ROCE of Biohaven Pharmaceutical Holding Company can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Biohaven Pharmaceutical Holding Company affect the company?

A decrease in ROCE of Biohaven Pharmaceutical Holding Company can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Biohaven Pharmaceutical Holding Company?

Some factors that can affect Biohaven Pharmaceutical Holding Company's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Biohaven Pharmaceutical Holding Company so important for investors?

The ROCE of Biohaven Pharmaceutical Holding Company is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Biohaven Pharmaceutical Holding Company take to improve the ROCE?

To improve the ROCE, Biohaven Pharmaceutical Holding Company can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Biohaven Pharmaceutical Holding Company pay?

Over the past 12 months, Biohaven Pharmaceutical Holding Company paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Biohaven Pharmaceutical Holding Company is expected to pay a dividend of 0 USD.

What is the dividend yield of Biohaven Pharmaceutical Holding Company?

The current dividend yield of Biohaven Pharmaceutical Holding Company is .

When does Biohaven Pharmaceutical Holding Company pay dividends?

Biohaven Pharmaceutical Holding Company pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Biohaven Pharmaceutical Holding Company?

Biohaven Pharmaceutical Holding Company paid dividends every year for the past 0 years.

What is the dividend of Biohaven Pharmaceutical Holding Company?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Biohaven Pharmaceutical Holding Company located?

Biohaven Pharmaceutical Holding Company is assigned to the 'Health' sector.

Wann musste ich die Aktien von Biohaven Pharmaceutical Holding Company kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Biohaven Pharmaceutical Holding Company from 9/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.

When did Biohaven Pharmaceutical Holding Company pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Biohaven Pharmaceutical Holding Company in the year 2023?

In the year 2023, Biohaven Pharmaceutical Holding Company distributed 0 USD as dividends.

In which currency does Biohaven Pharmaceutical Holding Company pay out the dividend?

The dividends of Biohaven Pharmaceutical Holding Company are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Biohaven Pharmaceutical Holding Company

Our stock analysis for Biohaven Pharmaceutical Holding Company Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biohaven Pharmaceutical Holding Company Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.